| 16962-3 | Heterophile Ab (Synovial Fluid, qualitative, latex agglutination) | MICRO |
| 16963-1 | Hexacarboxylporphyrin (Blood) | CHEM |
| 16964-9 | Hexacarboxylporphyrin (Stool) | CHEM |
| 16965-6 | Lindane (Blood) | DRUG/TOX |
| 16966-4 | Hexachloroethane (Blood) | DRUG/TOX |
| 16967-2 | Hexokinase 1 (Red Blood Cells) | CHEM |
| 16968-0 | Hexokinase 3 (Red Blood Cells) | CHEM |
| 16969-8 | Histone H2a+H2b Ab (immunofluorescence) | SERO |
| 1697-2 | 6-Phosphogluconate dehydrogenase (Red Blood Cells) | CHEM |
| 16970-6 | Histoplasma capsulatum Ab (qualitative, complement fixation) | MICRO |
| 16971-4 | Histoplasma capsulatum IgA Ab (qualitative, immune diffusion (id)) | MICRO |
| 16972-2 | Histoplasma capsulatum IgE Ab (qualitative, immune diffusion (id)) | MICRO |
| 16973-0 | Histoplasma capsulatum IgM Ab (qualitative, immune diffusion (id)) | MICRO |
| 16974-8 | HIV 1 Ab (CSF, qualitative) | MICRO |
| 16975-5 | HIV 1 IgG Ab (qualitative) | MICRO |
| 16976-3 | HIV 1 Ag | MICRO |
| 16977-1 | HIV 1 Ag (CSF, qualitative) | MICRO |
| 16978-9 | HIV 1 p24 Ab | MICRO |
| 16979-7 | HIV 1 p24 Ag (CSF) | MICRO |
| 1698-0 | 8-Hydroxyamoxapine | DRUG/TOX |
| 16980-5 | HTLV II DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 16981-3 | HTLV I DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 16982-1 | HTLV I+II Ab (qualitative, immunoblot) | MICRO |
| 16983-9 | hydrALAZINE (Urine, qualitative) | DRUG/TOX |
| 16984-7 | Hydrastine (Urine, qualitative) | DRUG/TOX |
| 16985-4 | Hydrogen/Expired gas in Exhaled gas --1.5 hours post dose glucose | CHAL |
| 16986-2 | Hydrogen/Expired gas in Exhaled gas --1 hour post dose glucose | CHAL |
| 16987-0 | Hydrogen/Expired gas in Exhaled gas --2.5 hours post dose glucose | CHAL |
| 16988-8 | Hydrogen/Expired gas in Exhaled gas --2 hours post dose glucose | CHAL |
| 16989-6 | Hydrogen/Expired gas in Exhaled gas --3.5 hours post dose glucose | CHAL |
| 1699-8 | Alpha-L-iduronidase (Tissue) | CHEM |
| 16990-4 | Hydrogen/Expired gas in Exhaled gas --3 hours post dose glucose | CHAL |
| 16991-2 | Hydrogen/Expired gas in Exhaled gas --4.5 hours post dose glucose | CHAL |
| 16992-0 | Hydrogen/Expired gas in Exhaled gas --4 hours post dose glucose | CHAL |
| 16993-8 | Hydrogen/Expired gas in Exhaled gas --5.5 hours post dose glucose | CHAL |
| 16994-6 | Hydrogen/Expired gas in Exhaled gas --5 hours post dose glucose | CHAL |
| 16995-3 | Hydrogen/Expired gas in Exhaled gas --6 hours post dose glucose | CHAL |
| 16996-1 | Hydrogen/Expired gas in Exhaled gas --pre dose glucose | CHAL |
| 16997-9 | Hydrogen/Expired gas in Exhaled gas --post dose glucose | CHAL |
| 16998-7 | HYDROmorphone (Urine, confirmatory method) | DRUG/TOX |
| 16999-5 | Hydroquinone (Urine) | DRUG/TOX |
| 17-4 | Amoxicillin (disk diffusion (kb)) | ABXBACT |
| 170-1 | Cephradine (disk diffusion (kb)) | ABXBACT |
| 1700-4 | Acetaldehyde (Blood) | DRUG/TOX |
| 17000-1 | Hydroxylysine (Urine, qualitative) | CHEM |
| 17001-9 | Hydroxyproline (Urine, qualitative) | CHEM |
| 17002-7 | Hydroxytriazolam (confirmatory method) | DRUG/TOX |
| 17003-5 | Serotonin (Urine) | CHEM |
| 17004-3 | Hypoxanthine (Urine) | CHEM |
| 17005-0 | IgA subclass 1 (CSF) | CHEM |